rs147324129
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_005506.4(SCARB2):c.1010T>C(p.Met337Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000102 in 1,613,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005506.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCARB2 | NM_005506.4 | c.1010T>C | p.Met337Thr | missense_variant | Exon 8 of 12 | ENST00000264896.8 | NP_005497.1 | |
SCARB2 | NM_001204255.2 | c.581T>C | p.Met194Thr | missense_variant | Exon 5 of 9 | NP_001191184.1 | ||
SCARB2 | XM_047416429.1 | c.536T>C | p.Met179Thr | missense_variant | Exon 8 of 12 | XP_047272385.1 | ||
SCARB2 | XM_047416430.1 | c.536T>C | p.Met179Thr | missense_variant | Exon 8 of 12 | XP_047272386.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152224Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 251216Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135764
GnomAD4 exome AF: 0.000103 AC: 151AN: 1461532Hom.: 0 Cov.: 31 AF XY: 0.000105 AC XY: 76AN XY: 727106
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152342Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74504
ClinVar
Submissions by phenotype
not provided Uncertain:2
Identified in a patient with epilepsy in published literature (PMID: 29358611); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29358611) -
- -
Self-limited epilepsy with centrotemporal spikes Pathogenic:1
CAADphred>15 -
Inborn genetic diseases Uncertain:1
The p.M337T variant (also known as c.1010T>C), located in coding exon 8 of the SCARB2 gene, results from a T to C substitution at nucleotide position 1010. The methionine at codon 337 is replaced by threonine, an amino acid with similar properties. This variant was detected in a cohort of individuals with Rolandic epilepsy; however, complete genotype and phenotype information was not provided (Bobbili DR et al. Eur. J. Hum. Genet., 2018 Feb;26:258-264). This amino acid position is poorly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on available evidence to date, the clinical significance of this alteration remains unclear. -
Action myoclonus-renal failure syndrome Uncertain:1
- -
Progressive myoclonic epilepsy Uncertain:1
This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 337 of the SCARB2 protein (p.Met337Thr). This variant is present in population databases (rs147324129, gnomAD 0.01%). This missense change has been observed in individual(s) with Rolandic epilepsy (PMID: 29358611). ClinVar contains an entry for this variant (Variation ID: 206715). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at